- 
                        From arousal to awareness: demystifying Female Sexual Arousal Disorder (Candace Syndrome)
                        23 May 2025 04:18 GMT
                        
                           … .
                          What is Female Sexual Arousal Disorder (FSAD) or “Candace Syndrome”?
                          According to Bester, Female Sexual Arousal Disorder (FSAD …
                         
- 
                        Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)
                        16 Dec 2024 13:00 GMT
                         … trial for the treatment of female sexual arousal disorder.” The Journal of Sexual … Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial.” … ingredient in Viagra®, to treat female sexual arousal disorder (FSAD); and DARE-HRT1, … 
- 
                        Sildenafil cream demonstrates safety, efficacy in phase 2b study for female sexual arousal disorder
                        11 Dec 2024 16:55 GMT
                         … , an investigational topical treatment for female sexual arousal disorder (FSAD). The findings, published in …  cream for the treatment of female sexual arousal disorder. Sex Med. 2024 Nov 19 … 
- 
                        Research Study Opportunity: Investigational medication for the treatment of Female Sexual Arousal Disorder (FSAD) in postmenopausal women
                        04 Sep 2024 00:08 GMT
                         …  medication for the treatment of Female Sexual Arousal Disorder (FSAD) in postmenopausal women who … 
- 
                        Topical sildenafil cream may improve outcomes among women with female sexual arousal disorder, claims study
                        13 Jul 2024 01:18 GMT
                         …  included women with only female sexual arousal disorder and those with female sexual arousal disorder with concomitant sexual …  cream, improve, outcomes, among, women, female, sexual, arousal disorder, study, Obstetrics & Gynecology, Johnson … 
- 
                        Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder
                        24 Jun 2024 12:00 GMT
                         … improved outcomes among women with female sexual arousal disorder (FSAD), particularly in  …  for the treatment of female sexual arousal disorder (FSAD). The Phase  … Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial … 
- 
                        What is female sexual arousal disorder? Know its causes and how to fix it
                        27 Apr 2024 04:44 GMT
                        
                           …  is a symptom of female sexual arousal disorder. Image courtesy: FreepikWhat … treat female sexual arousal disorder?
                          Here are some ways to treat female sexual arousal disorder:
                          1 …  is beneficial when treating female sexual arousal disorder. “Reduced arousal and …
                         
- 
                        Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024
                        31 Jan 2024 13:00 GMT
                         …  Cream) for the treatment of female sexual arousal disorder (FSAD) to a Phase 3 …  ingredient in Viagra®, to treat female sexual arousal disorder (FSAD); and DARE-HRT1, a … 
- 
                        Daré Bioscience Announces Upcoming Webinar to Review Additional Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder
                        06 Jul 2023 12:00 GMT
                         … , 3.6% in women with female sexual arousal disorder (FSAD). In addition to the …  formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in … 
- 
                        Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic…
                        06 Oct 2025 12:00 GMT
                         …  drug for men, to treat female sexual arousal disorder (FSAD); and DARE-HRT1, a …